Experimental study on the effects of simvastatin in reversing the femoral metaphyseal defects induced by sodium valproate in normal and ovariectomized rats

Introduction: Long-term treatment with antiepileptic drugs may cause secondary osteoporosis. The present study investigated the influence of simvastatin (SIM) in reversing the effects of valproate on bone defect healing in normal and ovariectomized (OVX) rats. Methods: Bone defects in femora were es...

Full description

Bibliographic Details
Main Authors: Yang Li, Ruotian Zhang, Maoxian Ren, Hedong Liu, Min Yang
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844022017686
_version_ 1811255017842147328
author Yang Li
Ruotian Zhang
Maoxian Ren
Hedong Liu
Min Yang
author_facet Yang Li
Ruotian Zhang
Maoxian Ren
Hedong Liu
Min Yang
author_sort Yang Li
collection DOAJ
description Introduction: Long-term treatment with antiepileptic drugs may cause secondary osteoporosis. The present study investigated the influence of simvastatin (SIM) in reversing the effects of valproate on bone defect healing in normal and ovariectomized (OVX) rats. Methods: Bone defects in femora were established in seven experimental groups of rats: control (vehicle), sodium valproate (SVP; 300 mg/kg/d), SVP plus SIM (25 mg/kg/d), sham control (sham), OVX, OVX SVP and OVX SVP plus SIM. All rats were euthanized at 8 weeks after bone defect creation. Results: Micro-CT, biomechanical and histological evaluations demonstrated lower bone strength and delayed bone healing in the SVP therapy group compared with the SVP plus SIM therapy group. Biochemical and immunohistochemical results showed that osteocalcin (OCN), collagen I (Col I) and procollagen type I N-terminal propeptide (P1NP) levels decreased, tartrate-resistant acid phosphatase type 5 precursor (TRACP-5b) expression increased, and Dickkopf-1 (DKK-1) and receptor activator of nuclear factor-κ B ligand (RANKL) expression were upregulated in the SVP therapy rats compared with the SVP plus SIM therapy group. Bone loss was exacerbated by OVX, but the effect of SIM in ameliorating bone loss was also more marked in the OVX rats. Conclusions: This study indicated lower bone strength and delayed healing of bone defects in rats given SVP therapy, especially the OVX SVP treatment group. In contrast, treatment with SIM was effective in enhancing bone strength and promoting bone defect repair and showed significant influence on promoting osteogenesis and inhibiting osteoclastogenesis.
first_indexed 2024-04-12T17:17:24Z
format Article
id doaj.art-f24d639c1b6e4756827b010a6b72e54e
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-12T17:17:24Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-f24d639c1b6e4756827b010a6b72e54e2022-12-22T03:23:37ZengElsevierHeliyon2405-84402022-09-0189e10480Experimental study on the effects of simvastatin in reversing the femoral metaphyseal defects induced by sodium valproate in normal and ovariectomized ratsYang Li0Ruotian Zhang1Maoxian Ren2Hedong Liu3Min Yang4Department of Trauma Orthopedics, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, PR ChinaDepartment of Trauma Orthopedics, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, PR ChinaDepartment of Trauma Orthopedics, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, PR ChinaDepartment of Trauma Orthopedics, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, PR ChinaCorresponding author.; Department of Trauma Orthopedics, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, PR ChinaIntroduction: Long-term treatment with antiepileptic drugs may cause secondary osteoporosis. The present study investigated the influence of simvastatin (SIM) in reversing the effects of valproate on bone defect healing in normal and ovariectomized (OVX) rats. Methods: Bone defects in femora were established in seven experimental groups of rats: control (vehicle), sodium valproate (SVP; 300 mg/kg/d), SVP plus SIM (25 mg/kg/d), sham control (sham), OVX, OVX SVP and OVX SVP plus SIM. All rats were euthanized at 8 weeks after bone defect creation. Results: Micro-CT, biomechanical and histological evaluations demonstrated lower bone strength and delayed bone healing in the SVP therapy group compared with the SVP plus SIM therapy group. Biochemical and immunohistochemical results showed that osteocalcin (OCN), collagen I (Col I) and procollagen type I N-terminal propeptide (P1NP) levels decreased, tartrate-resistant acid phosphatase type 5 precursor (TRACP-5b) expression increased, and Dickkopf-1 (DKK-1) and receptor activator of nuclear factor-κ B ligand (RANKL) expression were upregulated in the SVP therapy rats compared with the SVP plus SIM therapy group. Bone loss was exacerbated by OVX, but the effect of SIM in ameliorating bone loss was also more marked in the OVX rats. Conclusions: This study indicated lower bone strength and delayed healing of bone defects in rats given SVP therapy, especially the OVX SVP treatment group. In contrast, treatment with SIM was effective in enhancing bone strength and promoting bone defect repair and showed significant influence on promoting osteogenesis and inhibiting osteoclastogenesis.http://www.sciencedirect.com/science/article/pii/S2405844022017686Antiepileptic drugsSimvastatinSodium valproateOsteoporosisOvariectomized rats
spellingShingle Yang Li
Ruotian Zhang
Maoxian Ren
Hedong Liu
Min Yang
Experimental study on the effects of simvastatin in reversing the femoral metaphyseal defects induced by sodium valproate in normal and ovariectomized rats
Heliyon
Antiepileptic drugs
Simvastatin
Sodium valproate
Osteoporosis
Ovariectomized rats
title Experimental study on the effects of simvastatin in reversing the femoral metaphyseal defects induced by sodium valproate in normal and ovariectomized rats
title_full Experimental study on the effects of simvastatin in reversing the femoral metaphyseal defects induced by sodium valproate in normal and ovariectomized rats
title_fullStr Experimental study on the effects of simvastatin in reversing the femoral metaphyseal defects induced by sodium valproate in normal and ovariectomized rats
title_full_unstemmed Experimental study on the effects of simvastatin in reversing the femoral metaphyseal defects induced by sodium valproate in normal and ovariectomized rats
title_short Experimental study on the effects of simvastatin in reversing the femoral metaphyseal defects induced by sodium valproate in normal and ovariectomized rats
title_sort experimental study on the effects of simvastatin in reversing the femoral metaphyseal defects induced by sodium valproate in normal and ovariectomized rats
topic Antiepileptic drugs
Simvastatin
Sodium valproate
Osteoporosis
Ovariectomized rats
url http://www.sciencedirect.com/science/article/pii/S2405844022017686
work_keys_str_mv AT yangli experimentalstudyontheeffectsofsimvastatininreversingthefemoralmetaphysealdefectsinducedbysodiumvalproateinnormalandovariectomizedrats
AT ruotianzhang experimentalstudyontheeffectsofsimvastatininreversingthefemoralmetaphysealdefectsinducedbysodiumvalproateinnormalandovariectomizedrats
AT maoxianren experimentalstudyontheeffectsofsimvastatininreversingthefemoralmetaphysealdefectsinducedbysodiumvalproateinnormalandovariectomizedrats
AT hedongliu experimentalstudyontheeffectsofsimvastatininreversingthefemoralmetaphysealdefectsinducedbysodiumvalproateinnormalandovariectomizedrats
AT minyang experimentalstudyontheeffectsofsimvastatininreversingthefemoralmetaphysealdefectsinducedbysodiumvalproateinnormalandovariectomizedrats